Can-Fite secures FDA fast track designation for CF102 in HCC
Can-Fite has already secured the FDA’s Orphan Drug designation for CF102, which is a small orally bioavailable drug that binds with high affinity and selectivity to the A3
Can-Fite has already secured the FDA’s Orphan Drug designation for CF102, which is a small orally bioavailable drug that binds with high affinity and selectivity to the A3
Under the deal, if the company meets Phase 3 trial design objectives, it can seek regulatory approval of both TG-1101 and TGR-1202 in combination. The company will release
Vivolux said vast amounts of defective proteins formed in tumor cells disrupt the functioning of proteasome. The new mechanism of action by VLX1570 has been indicated to inhibit
Entresto is indicated to lower the risk of cardiovascular mortality and morbidity in patients with heart failure with reduced ejection fraction (HfrEF). It improves the protective neurohormonal systems
ALLDocs, also known as The Association of LensCrafters Leaseholding Doctors, is the second largest independent optometry group in the U.S. It works closely with its LensCrafters partners. "This
No adverse effects on cognition or emotional stability and no abuse potential were indicated with BNC210 reducing the effect of nicotine. The company enrolled 54 healthy volunteers and
The company carried out the trial at 12 sites in the US with 450 patients randomized to receive either ITI-007 60 mg or 40 mg or placebo once
The companies will advance new therapies that function via the ubiquitin proteasome system (UPS) for modulating protein homeostasis, a fundamental cellular process controlling protein levels. Celgene will pay
The breakthrough therapy designation is given to speed up the development and review of medicines with early signals of possible clinical benefit in serious diseases to make sure
The companies will work together in developing and commercializing novel therapeutics in the fields of cancer immunotherapy and inflammation. Amgen agreed to pay $45m upfront to license Xencor’s